SRPK1 and central nervous system cancer: Similar results were obtained in other glioma cell lines, such as a significant decrease in proliferation ability in U343 cells after silencing SRPK1 (Figure S5) and a significant inhibition of migration and invasion abilities (Figures S6 and S7).